HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Knockout of the neurokinin-1 receptor reduces cholangiocyte proliferation in bile duct-ligated mice.

Abstract
In bile duct-ligated (BDL) rats, cholangiocyte proliferation is regulated by neuroendocrine factors such as α-calcitonin gene-related peptide (α-CGRP). There is no evidence that the sensory neuropeptide substance P (SP) regulates cholangiocyte hyperplasia. Wild-type (WT, (+/+)) and NK-1 receptor (NK-1R) knockout (NK-1R(-/-)) mice underwent sham or BDL for 1 wk. Then we evaluated 1) NK-1R expression, transaminases, and bilirubin serum levels; 2) necrosis, hepatocyte apoptosis and steatosis, and the number of cholangiocytes positive by CK-19 and terminal deoxynucleotidyl transferase biotin-dUTP nick-end labeling in liver sections; 3) mRNA expression for collagen 1α and α-smooth muscle (α-SMA) actin in total liver samples; and 4) PCNA expression and PKA phosphorylation in cholangiocytes. In cholangiocyte lines, we determined the effects of SP on cAMP and D-myo-inositol 1,4,5-trisphosphate levels, proliferation, and PKA phosphorylation. Cholangiocytes express NK-1R with expression being upregulated following BDL. In normal NK-1R(-/-) mice, there was higher hepatocyte apoptosis and scattered hepatocyte steatosis compared with controls. In NK-1R (-)/(-) BDL mice, there was a decrease in serum transaminases and bilirubin levels and the number of CK-19-positive cholangiocytes and enhanced biliary apoptosis compared with controls. In total liver samples, the expression of collagen 1α and α-SMA increased in BDL compared with normal mice and decreased in BDL NK-1R(-/-) compared with BDL mice. In cholangiocytes from BDL NK-1R (-)/(-) mice there was decreased PCNA expression and PKA phosphorylation. In vitro, SP increased cAMP levels, proliferation, and PKA phosphorylation of cholangiocytes. Targeting of NK-1R may be important in the inhibition of biliary hyperplasia in cholangiopathies.
AuthorsShannon Glaser, Eugenio Gaudio, Anastasia Renzi, Romina Mancinelli, Yoshiyuki Ueno, Julie Venter, Mellanie White, Shelley Kopriva, Valorie Chiasson, Sharon DeMorrow, Heather Francis, Fanyin Meng, Marco Marzioni, Antonio Franchitto, Domenico Alvaro, Scott Supowit, Donald J DiPette, Paolo Onori, Gianfranco Alpini
JournalAmerican journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol) Vol. 301 Issue 2 Pg. G297-305 (Aug 2011) ISSN: 1522-1547 [Electronic] United States
PMID21596993 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Actins
  • Collagen Type I
  • Proliferating Cell Nuclear Antigen
  • RNA, Messenger
  • Receptors, Neurokinin-1
  • alpha-smooth muscle actin, mouse
  • Substance P
  • Inositol 1,4,5-Trisphosphate
  • Cyclic AMP
  • Aspartate Aminotransferases
  • Alanine Transaminase
  • Cyclic AMP-Dependent Protein Kinases
  • Bilirubin
Topics
  • Actins (metabolism)
  • Alanine Transaminase (blood)
  • Animals
  • Apoptosis
  • Aspartate Aminotransferases (blood)
  • Bile Ducts (metabolism, physiology, surgery)
  • Bilirubin (blood)
  • Cell Count
  • Cell Line
  • Cell Proliferation
  • Cholestasis (physiopathology)
  • Collagen Type I (metabolism)
  • Cyclic AMP (metabolism)
  • Cyclic AMP-Dependent Protein Kinases (chemistry)
  • Epithelial Cells (cytology, metabolism, physiology)
  • Hepatocytes (cytology)
  • Inositol 1,4,5-Trisphosphate (metabolism)
  • Ligation
  • Liver (metabolism, pathology)
  • Mice
  • Models, Animal
  • Necrosis
  • Phosphorylation
  • Proliferating Cell Nuclear Antigen (metabolism)
  • RNA, Messenger (metabolism)
  • Receptors, Neurokinin-1 (metabolism, physiology)
  • Signal Transduction (physiology)
  • Substance P (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: